Live Breaking News & Updates on Frederic Triebel

Stay updated with breaking news from Frederic triebel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immutep to Participate in November Investor Events

Immutep to Participate in November Investor Events
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New South Wales , Chris Basta , Wade Iams , Marc Voigt , Christian Mueller , Frederic Triebel , Immutep Limited , Corporate Communications , November Investor , Assistant Professor , Director Thoracic Clinical Trials , Vanderbilt University Medical Center , Lymphocyte Activation , Investor Relations ,

Immutep's Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer

Media Release Median Overall Survival reaches 35.5 months in first-line treatment of metastatic non-small cell lung cancer patients expressing PD-L1 (TPS >1%), 23.4 months in patients with low PD-L1 expression (TPS 1-49%), and has not been reached in patients with high PD-L1 expression (TPS >50%), exceeding expectationsPromising Overall Survival, Overall Response Rate, Progression Free Survival, and Duration of Response visible across all PD-L1 subgroups (TPS <1%, ≥1%, 1-49%, and ≥50%), differen ....

Comunidad Autonoma De Cataluna , United States , New South Wales , Frederic Triebel , Christian Mueller , Florian Vogl , Marc Voigt , Chris Basta , Enric Carcereny , Catalan Institute Of Oncology , Drug Administration , Merck Sharp Dohme , Corporate Communications , Strategic Development , Immutep Limited , Merck Co Inc , Media Release , Overall Survival , Overall Response Rate , Progression Free Survival , Catalan Institute , Mini Oral , Tumor Proportion Score , Doublet Chemo , Conference Call , Senior Vice President Strategic ,

Immutep (IMMP) Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023

Immutep (IMMP) Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marc Voigt , Frederic Triebel , I Sant Pau , Margarita Majem , Department Of Medical Oncology , European Lung Cancer Congress , Immutep Limited , Wall Street , Mini Oral , Lung Cancer Congress , Medical Oncology , Hospital De La Santa Creu , Sant Pau , Overall Survival , Tumour Growth Kinetics , Proportion Score ,